Relevant studies have shown that the expression level of IPO5 is significantly correlated with tumor immune lymphocytes, immunosuppressants, immune activators, and chemokines, which indicates that IPO5 can participate in tumor immune microenvironment and mediate tumor immune response [29, 28]. Here, IPO5 is linked to neoplasm.